Authors:
SMITH AD
GEISLER SC
CHEN AA
RESNICK DA
ROY BM
LEWI PJ
ARNOLD E
ARNOLD GF
Citation: Ad. Smith et al., HUMAN RHINOVIRUS TYPE-14 HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) V3 LOOP CHIMERAS FROM A COMBINATORIAL LIBRARY INDUCE POTENT NEUTRALIZING ANTIBODY-RESPONSES AGAINST HIV-1, Journal of virology, 72(1), 1998, pp. 651-659
Authors:
HOOKER DJ
TACHEDJIAN G
SOLOMON AE
GURUSINGHE AD
LAND S
BIRCH C
ANDERSON JL
ROY BM
ARNOLD E
DEACON NJ
Citation: Dj. Hooker et al., AN IN-VIVO MUTATION FROM LEUCINE TO TRYPTOPHAN AT POSITION-210 IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE CONTRIBUTES TO HIGH-LEVEL RESISTANCE TO 3'-AZIDO-3'-DEOXYTHYMIDINE, Journal of virology, 70(11), 1996, pp. 8010-8018
Authors:
ARNOLD E
DAS K
DING JP
HSIOU Y
TANTILLO C
ROY BM
YADAV P
ZHANG WY
LENTZ K
CLARK AD
BOYER PL
HUGHES SH
MITSUYA H
MELLORS J
KLEIM JP
ROSNER M
MOEREELS HR
KOYMANS L
ANDRIES K
PAUWELS R
JANSSEN PAJ
Citation: E. Arnold et al., THE ROLE OF NUCLEIC-ACID IN THE RESISTANCE OF HIV-1 REVERSE-TRANSCRIPTASE TO NUCLEOSIDE AND NONNUCLEOSIDE INHIBITORS, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 7-7
Authors:
MELLORS JW
BAZMI HZ
SCHINAZI RF
ROY BM
HSIOU Y
ARNOLD E
WEIR J
MAYERS DL
Citation: Jw. Mellors et al., NOVEL MUTATIONS IN REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REDUCE SUSCEPTIBILITY TO FOSCARNET IN LABORATORY AND CLINICAL ISOLATES, Antimicrobial agents and chemotherapy, 39(5), 1995, pp. 1087-1092
Authors:
SHIRASAKA T
KAVLICK MF
UENO T
GAO WY
KOJIMA E
ALCAIDE ML
CHOKEKIJCHAI S
ROY BM
ARNOLD E
YARCHOAN R
MITSUYA H
Citation: T. Shirasaka et al., EMERGENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS WITH RESISTANCE TO MULTIPLE DIDEOXYNUCLEOSIDES IN PATIENTS RECEIVING THERAPY WITHDIDEOXYNUCLEOSIDES, Proceedings of the National Academy of Sciences of the United Statesof America, 92(6), 1995, pp. 2398-2402